Celgene
Why Robinhood?
You can watch Celgene and buy or sell other stocks, ETFs, and their options commission-free!About CELG
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza.
CELG Key Statistics
Stock Snapshot
As of today, Celgene(CELG) shares are valued at $108.24. The company's market cap stands at 77.04B, with a P/E ratio of 13.32.
During the trading day, Celgene(CELG) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Celgene(CELG) stock has reached 0, versus its average volume of 27.24M.
The stock's 52-week range extends from a low of $58.59 to a high of $110.70.
The stock's 52-week range extends from a low of $58.59 to a high of $110.70.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.